ATRA-BA Hybrid – 10 mg

Brand:
Cayman
CAS:
1037543-26-2
Storage:
-20
UN-No:
Non-Hazardous - /

ATRA-BA hybrid is a mutual prodrug form of all-trans retinoic acid (ATRA; Item No. 11017) and butyric acid (BA; Item No. 13121).{57142} ATRA-BA hybrid is cleaved to release ATRA and BA in isolated mouse plasma. It inhibits the growth of MDA-MB-231 breast and PC3 prostate cancer cells with GI50 values of 0.01 and 1.02 µM, respectively. ATRA-BA (20 µM) has 15-fold greater antiproliferative activity in PC3 cells compared to an equimolar concentration of ATRA and BA.  

 

Available on backorder

SKU: 30982 - 10 mg Category:

Description

A mutual prodrug form of ATRA and BA; inhibits the growth of MDA-MB-231 breast and PC3 prostate cancer cells (GI50s = 0.01 and 1.02 µM, respectively); has 15-fold greater antiproliferative activity in PC3 cells compared to an equimolar concentration of ATRA and BA


Formal name: retinoic acid, 4-[(1-oxobutoxy)methyl]phenyl ester

Synonyms: 

Molecular weight: 476.7

CAS: 1037543-26-2

Purity: ≥95%

Formulation: A solid